# Impact of sleeve gastrectomy on bone metabolism in obese patients: from mechanisms to clinical prevention

**Authors:** Dawei Fan, Ce Fu, Baogang Zhu, Yan Wang, Pengfang Sheng, Jianghua Feng, Xiaopeng Wang

PMC · DOI: 10.3389/fmed.2026.1728174 · Frontiers in Medicine · 2026-02-18

## TL;DR

This paper reviews how sleeve gastrectomy affects bone health in obese patients and suggests ways to prevent bone-related issues.

## Contribution

The paper provides a comprehensive review of the mechanisms and prevention strategies for bone loss following sleeve gastrectomy.

## Key findings

- Sleeve gastrectomy increases bone resorption and decreases bone mineral density in obese patients.
- Bone microarchitecture is negatively affected by sleeve gastrectomy, increasing fracture risk.
- Clinical prevention strategies are proposed to mitigate bone-related complications post-surgery.

## Abstract

In recent years, the global incidence of obesity has continued to rise, making obesity and its associated complications a serious threat to human health. Bariatric surgery, represented by sleeve gastrectomy (SG), has emerged as a crucial intervention for the treatment of obesity and related metabolic comorbidities. However, accumulating evidence indicates that bariatric surgery exerts multiple adverse effects on bone tissue, characterized by significantly increased bone resorption, decreased bone mineral density (BMD), and a consequent elevation in fracture risk. This review summarizes the effects of SG on BMD, bone turnover markers (BTMs), and bone microarchitecture in obese individuals, and comprehensively discusses the underlying mechanisms as well as corresponding clinical prevention strategies.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PYY (peptide YY) [NCBI Gene 5697] {aka PYY-I, PYY1}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}, SHBG (sex hormone binding globulin) [NCBI Gene 6462] {aka ABP, SBP, TEBG}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, MAT1A (methionine adenosyltransferase 1A) [NCBI Gene 4143] {aka MAT, MATA1, SAMS, SAMS1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SOST (sclerostin) [NCBI Gene 50964] {aka CDD, DAND6, SOST1, VBCH}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}
- **Diseases:** calcium loss (MESH:D002128), estrogen deficiency (MESH:D056828), type 2 diabetes mellitus (MESH:D003924), Ovarian dysfunction (MESH:D010049), magnesium (MESH:D008275), abdominal obesity (MESH:D056128), Impaired nutrient absorption (MESH:C564600), hypertension (MESH:D006973), insulin resistance (MESH:D007333), osteoporosis (MESH:D010024), toxicity (MESH:D064420), weight loss (MESH:D015431), bone (MESH:D001847), Obesity (MESH:D009765), femoral neck (MESH:D005265), BMD (MESH:D001851), CTX (MESH:D019294), non-communicable (MESH:D000073296), Vitamin D (MESH:D014808), BTMs (MESH:D005600), metabolic abnormalities (MESH:D008659), bone fragility (MESH:C536063), sarcopenia (MESH:D055948), inflammatory (MESH:D007249), fracture (MESH:D050723), reduced bone strength (MESH:D001523), SHPT (MESH:D006962)
- **Chemicals:** steroid hormone (MESH:D013256), Calcium (MESH:D002118), SCFA (MESH:D005232), Bisphosphonates (MESH:D004164), magnesium (MESH:D008274), glucose (MESH:D005947), bile acid (MESH:D001647), 25(OH)D (-), teriparatide (MESH:D019379), vitamin D3 (MESH:D002762), butyrate (MESH:D002087), calcium citrate (MESH:D019355), testosterone (MESH:D013739), vitamin D (MESH:D014807), phosphorus (MESH:D010758), vitamin K2 (MESH:D024482)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Cosavirus F (no rank) [taxon 2003652], Homo sapiens (human, species) [taxon 9606], Clostridium butyricum (species) [taxon 1492]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956534/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956534/full.md

---
Source: https://tomesphere.com/paper/PMC12956534